Burkina Faso COVID-19 Preparedness and Response Project

Abstract*

The proposed Project will be part of the COVID-19 Strategic Preparedness and Response Program using the Multiphase Programmatic Approach (MPA). The proposed Project will fill critical financing gaps that have been identified due to the new emergency preparedness and response needs created by COVID-19. The proposed project will consist of two components: Component 1: Emergency COVID-19 Response; and Component 2: Implementation Management and Monitoring... Show More

Development Objective

To prevent, detect and respond to the threat posed by COVID-19, and strengthen national systems for public health preparedness in Burkina Faso.

Key Details

Project Details

Project ID
P173858
Status
Closed
Team Leader
Moussa Dieng
Borrower 2
Burkina Faso

Country
Burkina Faso
Disclosure Date
April 8, 2020
Approval Date
(as of board presentation)
April 28, 2020
Effective Date
June 3, 2020

Total Project Cost 1
US$ 21.15 million
Implementing Agency
Ministry of Health
Region
Western and Central Africa
Fiscal Year 3
2020

Commitment Amount
US$ 21.15 million
Environmental Category
N/A
Last Update Date
June 7, 2024
Closing Date
September 30, 2024

Consultant Services required
Yes
Last Stage Reached
BANK APPROVED

Associated Projects
P177535

Notes
1. Total project cost includes funding from World Bank and non-bank sources in US$ millions. Active and Closed projects show current commitments. Proposed (pipeline) and dropped projects show the forecast amount. The commitment amount for projects in the pipeline is indicative and may be modified during the project preparation.
2. Borrower refers to the Borrower of a Loan or Recipient of a Grant.
3. ”Fiscal Year” is the fiscal year in which the project was approved (or dropped if the status is dropped). The World Bank's fiscal year is from July 1 - June 30. For example, a fiscal year of 1996 corresponds to July 1, 1995 - June 30, 1996.

Sectors

Themes

FY17 - Human Development and Gender

FY17 - Disease Control100%
- FY17 - Pandemic Response100%
FY17 - Gender100%
FY17 - Health Systems and Policies100%
- FY17 - Health Finance100%
- FY17 - Health Service Delivery100%
- FY17 - Health System Strengthening100%
- FY17 - Private Sector Delivery in Health100%

FY17 - Social Development and Protection

FY17 - Social Protection100%
- FY17 - Social Safety Nets100%

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

Financier	Commitments
IDA Grant	10.57
IDA Credit	10.57

Total Project Financing (US$ Millions)

Product Line	IBRD/IDA
IBRD Commitment	N/A
IDA Commitment	21.15
IBRD + IDA Commitment	21.15

Lending Instrument
Grant Amount	N/A
Total Project Cost**	21.15

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

No data available.

Detailed Financial Activity as of March 31, 2025

Download:

Period	Financier	Transaction Type	Amount (US$)
Dec 30, 2021	IDA-D6310	Loan Disb	110,146.05
Nov 24, 2021	IDA-D6310	Loan Disb	648,997.70
Jun 30, 2021	IDA-D6310	Loan Disb	667,287.60
Jun 7, 2021	IDA-D6310	Loan Disb	1,016,466.56
Jul 13, 2021	IDA-D6310	Loan Disb	2,065,224.10
Dec 10, 2020	IDA-D6310	Loan Disb	165,301.66
Jul 27, 2020	IDA-D6310	Loan Disb	2,652,848.20
Dec 23, 2020	IDA-D6310	Loan Disb	2,037,303.20
Oct 4, 2021	IDA-66380	Loan Disb	2,899,771.20
Apr 15, 2022	IDA-66380	Int Charges	32,145.50
Apr 15, 2022	IDA-66380	Int Charges	32,145.50
Apr 15, 2021	IDA-66380	Int Charges	10,259.87
Apr 15, 2021	IDA-66380	Int Charges	10,259.87
Jun 30, 2021	IDA-66380	Loan Disb	437,184.20
Jun 7, 2021	IDA-66380	Loan Disb	921,638.25
Sep 3, 2021	IDA-66380	Loan Disb	828,945.75
Oct 15, 2021	IDA-66380	Int Charges	16,223.77
Oct 15, 2021	IDA-66380	Int Charges	16,223.77
Jun 7, 2021	IDA-66380	Loan Disb	1,171,943.90
Jul 27, 2020	IDA-66380	Loan Disb	2,681,540.00
Oct 15, 2020	IDA-66380	Int Charges	4,354.34
Oct 15, 2020	IDA-66380	Int Charges	4,354.34
Jun 2, 2022	IDA-66380	Loan Disb	61,522.71
Jun 2, 2022	IDA-66380	Loan Disb	729,496.20
Apr 15, 2022	IDA-66380	Int Charges	1,278.56
Apr 15, 2022	IDA-66380	Int Charges	1,278.56
Dec 29, 2021	IDA-66380	Loan Disb	691,390.60
Oct 15, 2022	IDA-66380	Int Charges	31,864.57
Oct 15, 2022	IDA-66380	Int Charges	31,864.57
Aug 29, 2024	IDA-71920	Loan Disb	1,029,197.06
Apr 18, 2024	IDA-71920	Int Charges	1,142.75
Apr 18, 2024	IDA-71920	Int Charges	1,142.75
Sep 12, 2023	IDA-71920	Loan Disb	184,772.44
Jun 26, 2023	IDA-71920	Loan Disb	285,409.06
Nov 15, 2023	IDA-71920	Int Charges	3,002.42
Nov 15, 2023	IDA-71920	Int Charges	12,040.89
Nov 15, 2023	IDA-71920	Int Charges	12,040.89
Jan 2, 2024	IDA-71920	Loan Disb	682,430.50
May 16, 2023	IDA-66380	Loan Disb	34,012.27
Apr 19, 2023	IDA-66380	Int Charges	36,580.92
Apr 19, 2023	IDA-66380	Int Charges	36,580.92
Apr 25, 2023	IDA-66380	Loan Disb	475,533.16
Feb 17, 2023	IDA-71920	Loan Disb	2,429,427.50
May 8, 2023	IDA-66380	Loan Disb	344,923.70
Jul 21, 2023	IDA-71920	Loan Disb	1,215,284.40
Apr 18, 2024	IDA-71920	Int Charges	48,049.73
Apr 18, 2024	IDA-71920	Int Charges	48,049.73
Apr 18, 2024	IDA-66380	Int Charges	38,820.05
Apr 18, 2024	IDA-66380	Int Charges	38,820.05
Feb 8, 2024	IDA-71920	Loan Disb	136,958.81
Jun 11, 2024	IDA-71920	Loan Disb	475,650.12
Jan 19, 2024	IDA-71920	Loan Disb	605,656.25
May 15, 2024	IDA-71920	Loan Disb	61,336.43
Apr 2, 2024	IDA-71920	Loan Disb	138,929.56
May 17, 2024	IDA-71920	Loan Disb	-436,956.94
Jul 18, 2024	IDA-71920	Loan Disb	310,046.28
Jun 25, 2024	IDA-71920	Loan Disb	318,606.38
Dec 21, 2023	IDA-71920	Loan Disb	548,313.70
Oct 6, 2023	IDA-71920	Loan Disb	1,006,175.06
Nov 30, 2023	IDA-71920	Loan Disb	547,613.50
Sep 29, 2023	IDA-71920	Loan Disb	1,100,464.90
Sep 29, 2023	IDA-71920	Loan Disb	1,360,081.00
Dec 8, 2023	IDA-71920	Loan Disb	229,250.55
Jun 14, 2024	IDA-71920	Loan Disb	479,985.44
Jul 25, 2024	IDA-71920	Loan Disb	509,267.47
Nov 15, 2023	IDA-66380	Int Charges	39,228.79
Nov 15, 2023	IDA-66380	Int Charges	39,228.79
Nov 15, 2023	IDA-71920	Int Charges	3,002.42
Apr 25, 2024	IDA-71920	Loan Disb	133,323.08
Jan 26, 2024	IDA-71920	Loan Disb	8,435,271.00
Aug 29, 2024	IDA-71920	Loan Disb	376,615.16
Jun 28, 2022	IDA-71920	Loan Commitment	24,150,000.00
Jun 28, 2022	IDA-E1100	Loan Commitment	24,150,000.00
Apr 28, 2020	IDA-66380	Loan Commitment	10,575,000.00
Apr 28, 2020	IDA-D6310	Loan Commitment	10,575,000.00
Jan 23, 2024	IDA-E1100	Loan Disb	13,080,312.00
Jul 26, 2024	IDA-E1100	Loan Disb	-115,606.18
May 15, 2024	IDA-E1100	Loan Disb	-158,236.36
May 15, 2024	IDA-E1100	Loan Disb	-4,149,165.00
May 31, 2023	IDA-E1100	Loan Disb	907,200.00
May 31, 2023	IDA-E1100	Loan Disb	1,102,248.00
Jun 1, 2023	IDA-E1100	Loan Disb	3,306,744.00
Nov 27, 2023	IDA-E1100	Loan Disb	2,308,550.50
May 12, 2023	IDA-D6310	Loan Disb	10,683.63
Apr 25, 2023	IDA-D6310	Loan Disb	105,256.97
Feb 21, 2023	IDA-D6310	Loan Disb	692,322.50
Jan 31, 2023	IDA-D6310	Loan Disb	443,638.47
Mar 22, 2023	IDA-E1100	Loan Disb	2,755,824.20
Jun 23, 2022	IDA-D6310	Loan Disb	115,325.59
Jun 28, 2022	IDA-D6310	Loan Disb	259,475.14

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name	Review	Date
Progress towards achievement of PDO	Satisfactory	2024-12-13
Financial Management	Satisfactory	2024-12-13
Monitoring and Evaluation	Satisfactory	2024-12-13
Overall Implementation Progress (IP)	Satisfactory	2024-12-13
Procurement	Moderately Satisfactory	2024-12-13
Project Management	Satisfactory	2024-12-13

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Percentage of females fully vaccinated against COVID-19 Value 40.00 55.91 50.00
Date January 14, 2022 October 31, 2023 June 29, 2024
Comment

Coordinated disease surveillance systems in place in the animal health and public health sectors for zoonotic diseases/pathogens identified as joint priorities	Value	No	Yes	Yes
	Date	April 8, 2020	April 29, 2022	April 29, 2022
	Comment

Policies, regulations, guidelines, or other relevant government strategic documents incorporating a multisectoral health approach developed/or revised and adopted	Value	No	Yes	Yes
	Date	April 8, 2020	April 29, 2022	April 29, 2022
	Comment

Number of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents Value 1.00 24.00 4.00
Date March 23, 2020 April 29, 2022 April 29, 2022
Comment

Percentage of suspected COVID-19 cases reported and investigated based on national guidelines for the emergency aspect of the project surveillance activities	Value	0.00	96.56	90.00
	Date	April 8, 2020	April 29, 2022	April 29, 2022
	Comment

Outbreak/pandemic emergency risk communication plan and activities developed and tested Value No Yes Yes
Date March 24, 2020 April 29, 2022 April 29, 2022
Comment
Targeted population fully vaccinated against COVID-19 based on the targets defined in national plan, disaggregated by gender Value 1.60 23.70 40.00
Date January 14, 2022 October 31, 2023 June 29, 2024
Comment
Infants 0-11 months who received Pentavalent 3 vaccine Value 624687.00 660499.00 436964.00
Date January 14, 2022 October 31, 2023 June 29, 2024
Comment

INTERMEDIATE RESULTS INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Medical waste security boxes that are destroyed Value 15.00 100.00 80.00
Date January 14, 2022 October 31, 2023 June 29, 2024
Comment
Vaccination sites that transmit their data in DHIS2 Value 18.56 100.00 95.00
Date January 14, 2022 October 31, 2023 June 29, 2024
Comment
Sites with climate- sensitive / energy efficient cold chain equipment to store COVID-19 vaccines Value 0.00 170.00 250.00
Date January 14, 2022 October 31, 2023 June 29, 2024
Comment
Healthcare workers trained on GBV Value 0.00 205.00 5200.00
Date January 14, 2022 October 31, 2023 June 29, 2024
Comment
M&E system established to monitor COVID-19 preparedness and response plan Value No Yes Yes
Date April 8, 2020 April 29, 2022 April 29, 2022
Comment

Number of health staff from peripheral health facilities trained on COVID-19 community surveillance per MOH-approved protocols	Value	0.00	108.00	4000.00
	Date	April 8, 2020	April 30, 2023	December 31, 2023
	Comment

Number of designated laboratories with staff trained to conduct COVID-19 diagnosis Value 2.00 24.00 24.00
Date April 8, 2020 December 31, 2023 December 31, 2023
Comment
Grievances addressed within 2 weeks of initial complaint being recorded Value 0.00 100.00 80.00
Date January 14, 2022 October 31, 2023 June 29, 2024
Comment
Country has prepared a referral system to care for COVID-19 patients Value No Yes Yes
Date April 8, 2020 April 29, 2022 April 29, 2022
Comment
Country has reported to have contextualized their risk communication and community engagement strategies Value No Yes Yes
Date April 8, 2020 April 29, 2022 April 29, 2022
Comment
Number of WASH COVID-19 kits provided to health care facilities Value 0.00 1000.00 200.00
Date April 8, 2020 April 29, 2022 April 29, 2022
Comment
New users of modern contraceptive methods Value 304480.00 355131.00 170956.00
Date January 14, 2022 October 31, 2023 June 29, 2024
Comment
Deliveries assisted by a qualified health personnel Value 621787.00 669685.00 453749.00
Date January 14, 2022 October 31, 2023 June 29, 2024
Comment
Women who attended four antenatal care visit (ANC4) Value 433824.00 378178.00 364725.00
Date January 14, 2022 August 31, 2023 June 29, 2024
Comment
Meetings hosted by the Ministry of Health to review essential health services data to strengthen health services delivery Value 0.00 3.00 8.00
Date January 14, 2022 October 31, 2023 June 29, 2024
Comment
Severe adverse events following immunization (AEFI) reported and treated based on national guidelines Value 10.00 100.00 50.00
Date January 14, 2022 October 31, 2023 June 29, 2024
Comment

Villages where community healthcare workers conduct consultations with the communities to get their feedback on COVID-19 vaccination and prevention measures	Value	0.00	3031.00	2000.00
	Date	January 14, 2022	October 31, 2023	June 29, 2024
	Comment

Percentage of females fully vaccinated against COVID-19	Value	40.00	55.91	50.00
	Date	January 14, 2022	October 31, 2023	June 29, 2024
	Comment

Number of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents	Value	1.00	24.00	4.00
	Date	March 23, 2020	April 29, 2022	April 29, 2022
	Comment

Targeted population fully vaccinated against COVID-19 based on the targets defined in national plan, disaggregated by gender	Value	1.60	23.70	40.00
	Date	January 14, 2022	October 31, 2023	June 29, 2024
	Comment

Infants 0-11 months who received Pentavalent 3 vaccine	Value	624687.00	660499.00	436964.00
	Date	January 14, 2022	October 31, 2023	June 29, 2024
	Comment

Medical waste security boxes that are destroyed	Value	15.00	100.00	80.00
	Date	January 14, 2022	October 31, 2023	June 29, 2024
	Comment

Vaccination sites that transmit their data in DHIS2	Value	18.56	100.00	95.00
	Date	January 14, 2022	October 31, 2023	June 29, 2024
	Comment

Healthcare workers trained on GBV	Value	0.00	205.00	5200.00
	Date	January 14, 2022	October 31, 2023	June 29, 2024
	Comment

Number of designated laboratories with staff trained to conduct COVID-19 diagnosis	Value	2.00	24.00	24.00
	Date	April 8, 2020	December 31, 2023	December 31, 2023
	Comment

New users of modern contraceptive methods	Value	304480.00	355131.00	170956.00
	Date	January 14, 2022	October 31, 2023	June 29, 2024
	Comment

Deliveries assisted by a qualified health personnel	Value	621787.00	669685.00	453749.00
	Date	January 14, 2022	October 31, 2023	June 29, 2024
	Comment

Women who attended four antenatal care visit (ANC4)	Value	433824.00	378178.00	364725.00
	Date	January 14, 2022	August 31, 2023	June 29, 2024
	Comment

Severe adverse events following immunization (AEFI) reported and treated based on national guidelines	Value	10.00	100.00	50.00
	Date	January 14, 2022	October 31, 2023	June 29, 2024
	Comment

Burkina Faso COVID-19 Preparedness and Response Project

Abstract*

Development Objective

Key Details

Project Details

Sectors

Themes

Stay Connected, sign up for our:

Project Map

Finances

Financing Plan (US$ Millions)

Total Project Financing (US$ Millions)

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Detailed Financial Activity as of March 31, 2025

Ratings

IMPLEMENTATION RATINGS

COMPLETION RATINGS

INDEPENDENT EVALUATION RATINGS

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INTERMEDIATE RESULTS INDICATORS